160 related articles for article (PubMed ID: 30517671)
1. Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus).
Liu DX; Perry DL; DeWald LE; Cai Y; Hagen KR; Cooper TK; Huzella LM; Hart R; Bonilla A; Bernbaum JG; Janosko KB; Adams R; Johnson RF; Kuhn JH; Schnell MJ; Crozier I; Jahrling PB; de la Torre JC
J Infect Dis; 2019 May; 219(11):1818-1822. PubMed ID: 30517671
[TBL] [Abstract][Full Text] [Related]
2. A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.
Cai Y; Ye C; Cheng B; Nogales A; Iwasaki M; Yu S; Cooper K; Liu DX; Hart R; Adams R; Brady T; Postnikova EN; Kurtz J; St Claire M; Kuhn JH; de la Torre JC; Martínez-Sobrido L
mBio; 2020 Feb; 11(1):. PubMed ID: 32098811
[TBL] [Abstract][Full Text] [Related]
3. Virulent infection of outbred Hartley guinea pigs with recombinant Pichinde virus as a surrogate small animal model for human Lassa fever.
Lan S; Shieh WJ; Huang Q; Zaki SR; Liang Y; Ly H
Virulence; 2020 Dec; 11(1):1131-1141. PubMed ID: 32799623
[TBL] [Abstract][Full Text] [Related]
4. Lassa virus antigen distribution and inflammation in the ear of infected strain 13/N Guinea pigs.
Huynh T; Gary JM; Welch SR; Coleman-McCray J; Harmon JR; Kainulainen MH; Bollweg BC; Ritter JM; Shieh WJ; Nichol ST; Zaki SR; Spiropoulou CF; Spengler JR
Antiviral Res; 2020 Nov; 183():104928. PubMed ID: 32898586
[TBL] [Abstract][Full Text] [Related]
5. Temporal Progression of Lesions in Guinea Pigs Infected With Lassa Virus.
Bell TM; Shaia CI; Bearss JJ; Mattix ME; Koistinen KA; Honnold SP; Zeng X; Blancett CD; Donnelly GC; Shamblin JD; Wilkinson ER; Cashman KA
Vet Pathol; 2017 May; 54(3):549-562. PubMed ID: 28438110
[TBL] [Abstract][Full Text] [Related]
6. A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region.
Cai Y; Iwasaki M; Motooka D; Liu DX; Yu S; Cooper K; Hart R; Adams R; Burdette T; Postnikova EN; Kurtz J; St Claire M; Ye C; Kuhn JH; Martínez-Sobrido L; de la Torre JC
mBio; 2020 Mar; 11(2):. PubMed ID: 32209677
[TBL] [Abstract][Full Text] [Related]
7. Hearing loss in outbred Hartley guinea pigs experimentally infected with Pichinde virus as a surrogate model of human mammarenaviral hemorrhagic fevers.
Brisse M; Fernández-Alarcón C; Huang Q; Kirk N; Schleiss MR; Liang Y; Ly H
Virulence; 2022 Dec; 13(1):1049-1061. PubMed ID: 35758052
[TBL] [Abstract][Full Text] [Related]
8. Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.
Maruyama J; Manning JT; Mateer EJ; Sattler R; Bukreyeva N; Huang C; Paessler S
mSphere; 2019 Sep; 4(5):. PubMed ID: 31554720
[TBL] [Abstract][Full Text] [Related]
9. A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity.
Carrion R; Patterson JL; Johnson C; Gonzales M; Moreira CR; Ticer A; Brasky K; Hubbard GB; Moshkoff D; Zapata J; Salvato MS; Lukashevich IS
Vaccine; 2007 May; 25(20):4093-102. PubMed ID: 17360080
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337
[TBL] [Abstract][Full Text] [Related]
11. Current research for a vaccine against Lassa hemorrhagic fever virus.
Warner BM; Safronetz D; Stein DR
Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
[TBL] [Abstract][Full Text] [Related]
12. Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation.
Johnson DM; Cubitt B; Pfeffer TL; de la Torre JC; Lukashevich IS
Viruses; 2021 Jan; 13(2):. PubMed ID: 33573250
[TBL] [Abstract][Full Text] [Related]
13. Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin.
Jahrling PB
J Med Virol; 1983; 12(2):93-102. PubMed ID: 6619814
[TBL] [Abstract][Full Text] [Related]
14. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.
Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF
Virol J; 2011 Oct; 8():478. PubMed ID: 22023795
[TBL] [Abstract][Full Text] [Related]
15. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628
[TBL] [Abstract][Full Text] [Related]
16. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
[TBL] [Abstract][Full Text] [Related]
17. The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model.
Welch SR; Scholte FEM; Albariño CG; Kainulainen MH; Coleman-McCray JD; Guerrero LW; Chakrabarti AK; Klena JD; Nichol ST; Spengler JR; Spiropoulou CF
Front Cell Infect Microbiol; 2018; 8():240. PubMed ID: 30050872
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.
Lee AM; Cruite J; Welch MJ; Sullivan B; Oldstone MB
Virology; 2013 Aug; 442(2):114-21. PubMed ID: 23684417
[TBL] [Abstract][Full Text] [Related]
19. Immune-Mediated Systemic Vasculitis as the Proposed Cause of Sudden-Onset Sensorineural Hearing Loss following Lassa Virus Exposure in Cynomolgus Macaques.
Cashman KA; Wilkinson ER; Zeng X; Cardile AP; Facemire PR; Bell TM; Bearss JJ; Shaia CI; Schmaljohn CS
mBio; 2018 Oct; 9(5):. PubMed ID: 30377282
[TBL] [Abstract][Full Text] [Related]
20. Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques.
Rasmussen AL; Tchitchek N; Safronetz D; Carter VS; Williams CM; Haddock E; Korth MJ; Feldmann H; Katze MG
J Virol; 2015 Mar; 89(5):2543-52. PubMed ID: 25520505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
